软通道引流术治疗高血压脑出血的临床疗效

The Clinical Effect of Soft Channel Drainage in the Treatment of Hypertensive Cerebral Hemorrhage

目的探讨软通道引流术在高血压脑出血临床治疗中的应用疗效。方法方便选取该院2018年7月—2019年6月收治的90例高血压脑出血患者作为研究对象,分为A组(软通道引流术)、B组(开颅血肿清除术)和C组(小骨窗血肿清除术)各30例,观察各组患者的治疗效果及恢复情况。结果A组临床疗效显著高于B组和C组,差异有统计学意义(P<0.05),术后残疾和植物生存以及发生术后并发症的患者比例低于B组和C组,差异有统计学意义(P<0.05)。与治疗前相比,治疗3个月后3组患者的神经功能缺损程度(NHISS)评分显著降低,差异有统计学意义(P<0.05),肢体运动功能Fugl-Meyer(FMA)评定量表评分显著提升,差异有统计学意义(P<0.05),A组患者治疗后的NHISS评分为(14.63±2.67)分,比B组和C组更低,差异有统计学意义(P<0.05),FMA评分为(64.29±4.93)分,比B组和C组更高,差异有统计学意义(P<0.05),B组和C组之间对比差异无统计学意义(P>0.05)。A组患者的住院时间为(14.08±2.67)d,比B组和C组更短,差异有统计学意义(P<0.05),住院费用为(4.02±0.54)万元,比B组和C组更低,差异有统计学意义(P<0.05)。B组和C组之间对比差异无统计学意义(P>0.05)。结论在高血压脑出血的临床治疗中,软通道引流术是一种安全、有效的治疗选择,可以有效控制病情进展,改善患者的临床症状,降低疾病的危害性,改善患者预后。

Objective To explore the effect of soft channel drainage in the clinical treatment of hypertensive cerebral hemorrhage.Methods Ninety patients with hypertensive cerebral hemorrhage admitted to the hospital from July 2018 to June 2019 were convenient selected as the research objects,and they were divided into group A(soft channel drainage),group B(craniotomy hematoma removal)and group C(small bone window hematoma removal)30 cases in each group,observed the treatment effect and recovery of patients in each group.Results The clinical efficacy of group A was significantly higher than that of group B and C,the difference was statistically significant(P<0.05),and the proportion of patients with postoperative disability,plant survival and postoperative complications was lower than that of group B and C,the difference was statistically significant(P<0.05).Compared with before treatment,after 3 months of treatment,the neurological impairment(NHISS)score of the three groups of patients was significantly reduced,the difference was statistically significant(P<0.05),and the Fugl-Meyer(FMA)rating scale score of limb motor function was significantly improved,the difference was statistically significant(P<0.05),the NHISS score of the patients in group A after treatment was(14.63±2.67)points,which was lower than that of group B and C,the difference was statistically significant(P<0.05),and the FMA score was(64.29±4.93)points,which was higher than that of groups B and C,the difference was statistically significant(P<0.05),there was no statistically significant difference between group B and C(P>0.05).The hospitalization time of patients in group A was(14.08±2.67)d shorter than that of groups B and C,the difference was statistically significant(P<0.05),and the hospitalization cost was(4.02±0.54)ten thousand yuan,which was lower than that of group B and C,the difference was statistically significant(P<0.05).There was no statistically significant difference between group B and group C(P>0.05).Conclusion In the clinical treatment of hypertensive intracerebral hemorrhage,soft channel drainage is a safe and effective treatment option,which can effectively control the progression of the disease,improve the clinical symptoms of the patient,reduce the harm of the disease,and improve the prognosis of the patient.